Diabetes,Type 1 Diabetes,Type 2 Diabetes, Symptoms of Diabetes, Diabetes Treatment,Diabetes information,yoga and Diabetes,meditation and Diabetes,morning walk and Diabetes
← Previous Post
Next Post →

Endogenous Cushing’s Syndrome – FDA Approves Korlym (Mifepristone)

admin February 22, 2012 0


The U.S. Food and Drug Administration has approved Korlym (mifepristone) to control hyperglycemia (high blood sugar levels) in adults with endogenous Cushing’s syndrome, who have type 2 diabetes or gl


ose intolerance, who remained unresponsive to previous surgery or are not eligible candidates for surgery. Pregnant women should never take Korlym (contraindicated)…

Diabetes news and updates

Source: medicalnewstoday.com



You may also lik:

  1. Thousands Of Gestational Diabetes Cases Go Undetected, Study Says
  2. Scientists Reassess Weight Loss Surgery For Type 2 Diabetes
  3. Scientists Reassess Weight Loss Surgery For Type 2 Diabetes
  4. Thousands Of Gestational Diabetes Cases Go Undetected, Study Says
  5. Sitagliptin Is Safer And As Effective As Glipizide In Patients With Type 2 Diabetes And Chronic Kidney Disease
POSTED IN » Diabetes news and update
About the author: admin View all posts by

Leave A Response »